GTR Home > Tests > Search results - Peutz-Jeghers syndrome

Apply filters

Showing tests for all 65 conditions

Compare labs

GTR test search results for C0031269[DISCUI]

C Clinical test, R Research test

Showing 1 to 7 of 7 tests for 65 conditions in 1 lab

CHereditary breast cancer, extended panel

Lab: Invitae San Francisco, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (19)
Total targets (12)

CHereditary colon cancers

Lab: Invitae San Francisco, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (27)
Total targets (14)

CHereditary breast cancer, high-risk panel

Lab: Invitae San Francisco, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (16)
Total targets (7)

CWomen's hereditary cancer syndromes

Lab: Invitae San Francisco, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (31)
Total targets (17)

CHereditary cancer syndromes

Lab: Invitae San Francisco, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (61)
Total targets (26)

CPeutz-Jeghers syndrome

Lab: Invitae San Francisco, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CHereditary pancreatic cancer

Lab: Invitae San Francisco, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (19)
Total targets (17)

Showing 1 to 7 of 7 tests for 65 conditions in 1 lab

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.